Stephanie L. Coffing

765 total citations
26 papers, 649 citations indexed

About

Stephanie L. Coffing is a scholar working on Cancer Research, Molecular Biology and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Stephanie L. Coffing has authored 26 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cancer Research, 15 papers in Molecular Biology and 7 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Stephanie L. Coffing's work include Carcinogens and Genotoxicity Assessment (17 papers), DNA and Nucleic Acid Chemistry (6 papers) and Effects and risks of endocrine disrupting chemicals (5 papers). Stephanie L. Coffing is often cited by papers focused on Carcinogens and Genotoxicity Assessment (17 papers), DNA and Nucleic Acid Chemistry (6 papers) and Effects and risks of endocrine disrupting chemicals (5 papers). Stephanie L. Coffing collaborates with scholars based in United States and Germany. Stephanie L. Coffing's co-authors include William M. Baird, David J. Riese, Robert J. Mauthe, Albrecht Seidel, Andreas Luch, Krista L. Dobo, Maik Schuler, Robert P. Hammer, Yong Tang and Johannes Doehmer and has published in prestigious journals such as Oncogene, Journal of Medicinal Chemistry and Carcinogenesis.

In The Last Decade

Stephanie L. Coffing

26 papers receiving 635 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephanie L. Coffing United States 14 309 293 153 140 99 26 649
Sherry L. Ralston United States 10 272 0.9× 173 0.6× 71 0.5× 127 0.9× 76 0.8× 14 533
Garret B. Nelson United States 16 328 1.1× 373 1.3× 199 1.3× 53 0.4× 44 0.4× 40 656
Sipra Banerjee United States 19 596 1.9× 291 1.0× 75 0.5× 169 1.2× 84 0.8× 55 948
Aurora Viaje United States 19 511 1.7× 380 1.3× 129 0.8× 137 1.0× 115 1.2× 35 940
Margaret Gaskell United Kingdom 14 286 0.9× 167 0.6× 83 0.5× 80 0.6× 54 0.5× 17 579
Jennifer E. Foreman United States 16 453 1.5× 177 0.6× 97 0.6× 79 0.6× 41 0.4× 30 794
G. L. Gleason United States 11 482 1.6× 332 1.1× 129 0.8× 116 0.8× 88 0.9× 12 824
Larry P. Yotti United States 9 739 2.4× 282 1.0× 112 0.7× 102 0.7× 24 0.2× 12 1.1k
Ada Kolman Sweden 15 260 0.8× 293 1.0× 138 0.9× 55 0.4× 17 0.2× 52 619
Susumu Akasaka Japan 17 486 1.6× 202 0.7× 94 0.6× 184 1.3× 117 1.2× 34 885

Countries citing papers authored by Stephanie L. Coffing

Since Specialization
Citations

This map shows the geographic impact of Stephanie L. Coffing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephanie L. Coffing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephanie L. Coffing more than expected).

Fields of papers citing papers by Stephanie L. Coffing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephanie L. Coffing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephanie L. Coffing. The network helps show where Stephanie L. Coffing may publish in the future.

Co-authorship network of co-authors of Stephanie L. Coffing

This figure shows the co-authorship network connecting the top 25 collaborators of Stephanie L. Coffing. A scholar is included among the top collaborators of Stephanie L. Coffing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephanie L. Coffing. Stephanie L. Coffing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heard, Pamela L., et al.. (2017). Fluorescent tubulin polymerization assay to characterize moa of genotoxic compounds — A validation study. Journal of Pharmacological and Toxicological Methods. 85. 89–89. 1 indexed citations
2.
3.
Sobol, Zhanna, Richard A. Spellman, Dingzhou Li, et al.. (2012). Development and validation of an in vitro micronucleus assay platform in TK6 cells. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 746(1). 29–34. 28 indexed citations
4.
Dobo, Krista L., et al.. (2011). Defining EMS and ENU dose–response relationships using the Pig-a mutation assay in rats. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 725(1-2). 13–21. 42 indexed citations
5.
Cammerer, Zoryana, Javed A. Bhalli, Xuefei Cao, et al.. (2011). Report on stage III Pig‐a mutation assays using N‐ethyl‐N‐nitrosourea – comparison with other in vivo genotoxicity endpoints. Environmental and Molecular Mutagenesis. 52(9). 721–730. 35 indexed citations
6.
Coffing, Stephanie L., et al.. (2010). The rat gut micronucleus assay: A good choice for alternative in vivo genetic toxicology testing strategies. Environmental and Molecular Mutagenesis. 52(4). 269–279. 13 indexed citations
7.
Kalgutkar, Amit S., Deepak Dalvie, Jiri Aubrecht, et al.. (2007). Genotoxicity of 2-(3-Chlorobenzyloxy)-6-(piperazinyl)pyrazine, a Novel 5-Hydroxytryptamine2c Receptor Agonist for the Treatment of Obesity: Role of Metabolic Activation. Drug Metabolism and Disposition. 35(6). 848–858. 36 indexed citations
8.
VanBrocklin, Henry F., et al.. (2005). Anilinodialkoxyquinazolines:  Screening Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Potential Tumor Imaging Probes. Journal of Medicinal Chemistry. 48(23). 7445–7456. 30 indexed citations
9.
Hobbs, Stuart, Elizabeth Cameron, Robert P. Hammer, et al.. (2003). Five carboxyl-terminal residues of neuregulin2 are critical for stimulation of signaling by the ErbB4 receptor tyrosine kinase. Oncogene. 23(4). 883–893. 23 indexed citations
10.
Hobbs, Stuart, Stephanie L. Coffing, Elizabeth Cameron, et al.. (2002). Neuregulin isoforms exhibit distinct patterns of ErbB family receptor activation. Oncogene. 21(55). 8442–8452. 70 indexed citations
11.
Luch, Andreas, Stephanie L. Coffing, Albrecht Seidel, et al.. (2000). DNA Modification Induced After Metabolic Activation of the Potent Carcinogen Dibenzo[a, l]pyrene in V79 Chinese Hamster Cells Stably Expressing Single Cytochromes P450. Polycyclic aromatic compounds. 16(1-4). 71–78. 1 indexed citations
12.
Coffing, Stephanie L., et al.. (1999). Metabolic Activation of 4H-Cyclopenta[def]chrysene in Human Mammary Carcinoma MCF-7 Cell Cultures. Chemical Research in Toxicology. 12(5). 437–441. 4 indexed citations
13.
Luch, Andreas, Stephanie L. Coffing, Yong Tang, et al.. (1998). Stable Expression of Human Cytochrome P450 1B1 in V79 Chinese Hamster Cells and Metabolically Catalyzed DNA Adduct Formation of Dibenzo[a,l]pyrene. Chemical Research in Toxicology. 11(6). 686–695. 109 indexed citations
14.
Agarwal, Rachana, Stephanie L. Coffing, William M. Baird, et al.. (1997). Metabolic activation of benzo[g]chrysene in the human mammary carcinoma cell line MCF-7.. PubMed. 57(3). 415–9. 21 indexed citations
15.
16.
Mauthe, Robert J., et al.. (1995). Exposure of mammalian cell cultures to benzo[a] and light results in oxidative DNA damage as measured by 8-hydroxydeoxyguanosine formation. Carcinogenesis. 16(1). 133–137. 68 indexed citations
17.
Polzer, R J, Stephanie L. Coffing, Craig B. Marcus, et al.. (1995). Inhibition of benzo[a]pyrene metabolism by insulin, FITC-insulin and an FITC-insulin-antibody conjugate in the human hepatoma cell line HepG2. Chemico-Biological Interactions. 97(3). 307–318. 6 indexed citations
18.
19.
20.
Chae, Young-Heum, et al.. (1991). Effects of biochanin A on metabolism, DNA binding and mutagenicity of benzo [a]pyrene in mammalian cell cultures. Carcinogenesis. 12(11). 2001–2006. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sherry L. Ralston Breakdown of academic impact, for papers by Garret B. Nelson Breakdown of academic impact, for papers by Sipra Banerjee Breakdown of academic impact, for papers by Aurora Viaje Breakdown of academic impact, for papers by Margaret Gaskell Breakdown of academic impact, for papers by Jennifer E. Foreman Breakdown of academic impact, for papers by G. L. Gleason Breakdown of academic impact, for papers by Larry P. Yotti Breakdown of academic impact, for papers by Ada Kolman Breakdown of academic impact, for papers by Susumu Akasaka
Rankless by CCL
2026